Across the border: why international telehealth mostly fails the test

The short answer: usually no

Usually, no. Telehealth is regulated by the place where the patient is physically located, so when your patient is sitting in another country, the encounter falls under that country's medical and licensing laws — and your US state license does not authorize you to practice there 1Ref 1U.S. Department of Health and Human Services (2026).Licensure — Telehealth policy.That telehealth licensure follows the state where the patient is physically located, with compacts and state registration as the exceptions — so a US state license does not authorize practice where the patient is abroad.. Across the border, the framework you rely on inside the US simply stops applying, and a foreign government's rules take over.

Most international telehealth fails a basic test: you are not licensed where the care is actually delivered. Every country decides for itself who may practice medicine within its territory, and a US license — or several — carries no weight in that decision. This is not a documentation gap you can paper over; it is a jurisdictional wall. The honest default for a solo clinician whose patient has gone abroad is to pause the remote care until you have confirmed the rules of the country the patient is in, not to proceed and hope.

The licensing wall: your state license stops at the US border

Your authority to treat follows the patient, and it is granted by a US state — an authority that has no reach outside the United States 1Ref 1U.S. Department of Health and Human Services (2026).Licensure — Telehealth policy.That telehealth licensure follows the state where the patient is physically located, with compacts and state registration as the exceptions — so a US state license does not authorize practice where the patient is abroad.. When the patient is abroad, the relevant licensing body is that country's, and whether you may treat them at all is its question to answer, often requiring local authorization you do not have. Assuming a US license travels with the patient is the single most common and most costly mistake here.

The interstate compacts do not rescue this, because every one of them is an agreement among US states. PSYPACT for psychologists 2Ref 2PSYPACT Commission (2026).PSYPACT.That PSYPACT is an interstate arrangement authorizing telepsychology among participating US states — a domestic instrument that does not extend outside the United States. and the Interstate Medical Licensure Compact for physicians 3Ref 3Interstate Medical Licensure Compact Commission (2026).Interstate Medical Licensure Compact.That the IMLC expedites full medical licenses among US member states — a domestic pathway that grants no authority outside the United States. expand where you can practice within the country; neither extends one inch past the US border, and the same is true of the counseling, social work, and nurse compacts. They are domestic instruments for a domestic problem — a patient in another country is outside their entire design.

Prescribing across a border is a separate, harder no

If your care involves prescribing, treating a patient abroad adds a second wall on top of the licensing one. The current DEA and HHS posture on telemedicine prescribing of controlled substances is an extension regime built for prescribing within the United States, and it does not authorize cross-border prescriptions — read it as volatile, carry its as-of-July-2026 date, and do not stretch a domestic flexibility into an international one 4Ref 4U.S. Department of Health and Human Services (2026).Prescribing controlled substances via telehealth.That the current DEA/HHS telemedicine controlled-substance prescribing posture is a domestic extension regime, carried with its as-of-July-2026 date, that does not authorize cross-border prescriptions.. A foreign pharmacy operates under its own country's law, not the DEA's.

Cross-border prescriptions are their own category of problem: even DEA registrations across state lines are handled state by state inside the US, and none of that machinery reaches a patient standing in another country. If a traveling patient needs a prescription filled abroad, that is a matter for a clinician licensed in the destination country, not something your US registration can solve remotely.

HIPAA still binds you — and foreign data law may pile on

A patient leaving the country does not release you from HIPAA. If you are a covered entity, the Privacy Rule continues to govern how you use and disclose that patient's protected health information regardless of where they sit 5Ref 5HHS Office for Civil Rights (2026).Summary of the HIPAA Privacy Rule.That the Privacy Rule governs a covered entity's use and disclosure of PHI, which continues to apply regardless of where the patient is physically located.. The covered-entity test does not turn on the patient's geography; it turns on what you are and what you do, so your obligations to protect and account for the information travel with the record, not with the person.

On top of that, the country the patient is in may impose its own data-protection requirements on the handling of their information, and those can differ sharply from US rules. That layer is genuinely a question for counsel familiar with the specific jurisdiction rather than something to reason out from the US framework. The safe assumption is that a session with a patient abroad may trigger obligations in two legal systems at once, not one.

Coverage and malpractice: usually not there

Even if the licensing and prescribing walls did not exist, the money usually does not work either. Public and commercial coverage is built around US-based care: the telehealth billing framework assumes a US originating site and US place-of-service conventions, none of which fit a patient overseas 6Ref 6U.S. Department of Health and Human Services (2026).Billing for telehealth.That the telehealth billing framework is built around US originating sites and place-of-service conventions, which do not fit a patient located outside the United States.. In practice, a session delivered to a patient in another country is typically not a covered, payable service, so treat it as self-pay at best and confirm the specific plan's stance before assuming otherwise.

Malpractice coverage is the quieter risk. Many professional liability policies are written around a defined geographic scope and commonly exclude or limit claims arising from care delivered to patients outside the United States. Coverage across lines is not something to assume from a domestic policy — read the territory clause, and get written confirmation from your carrier before you agree to see a patient abroad, because discovering the gap after a claim is the worst time to learn it.

The narrow cases, and how to vet them

There are limited situations people ask about — most often an established US patient who travels overseas briefly and wants to keep a standing appointment. Even then, the analysis does not change: the controlling question is what the destination country permits, and the answer can range from a genuine exception to a flat prohibition. The safe sequence is to verify before the visit, not to proceed and reconcile later.

• Confirm the destination country's rules for a foreign clinician treating someone within its borders, ideally through counsel or the relevant embassy or licensing authority.
• Get written confirmation from your malpractice carrier that the encounter is within its territorial scope.
• Assume no third-party payment, and set the fee arrangement with the patient in advance.
• Keep prescribing off the table unless a clinician licensed in the destination country handles it.

Marketing across lines deserves the same honesty: do not advertise or imply you can routinely see patients in other countries when the licensing test says otherwise. Where the facts are genuinely uncertain, that uncertainty is exactly the trigger to bring in counsel who knows the specific jurisdiction — here is the checklist to hand them, not a reason to guess.